Jump to main content
Jump to site search

Issue 7, 2015
Previous Article Next Article

Photochemical internalization of bleomycin and temozolomide – in vitro studies on the glioma cell line F98

Author affiliations

Abstract

Here we evaluate the photosensitizer meso-tetraphenyl chlorin disulphonate (TPCS2a) in survival studies of rat glioma cancer cells in combination with the novel photochemical internalization (PCI) technique. The tested anticancer drugs were bleomycin (BLM) and temozolomide (TMZ). Glioma cells were incubated with TPCS2a (0.2 μg ml−1, 18 h, 37 °C) before BLM or TMZ stimulation (4 h) prior to red light illumination (652 nm, 50 mW cm−2). The cell survival after BLM (0.5 μm)-PCI (40 s light) quantified using the MTT assay was reduced to about 25% after 24 h relative to controls, and to 31% after TMZ-PCI. The supplementing quantification by clonogenic assays, using BLM (0.1 μm), indicated a long-term cytotoxic effect: the surviving fraction of clonogenic cells was reduced to 5% after light exposure (80 s) with PCI, compared to 70% in the case of PDT. In parallel, structural and morphological changes within the cells upon light treatment were examined using fluorescence microscopy techniques. The present study demonstrates that PCI of BLM is an effective method for killing F98 glioma cells, but smaller effects were observed using TMZ following the “light after” strategy. The results are the basis for further in vivo studies on our rat glioma cancer model using PDT and PCI.

Graphical abstract: Photochemical internalization of bleomycin and temozolomide – in vitro studies on the glioma cell line F98

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Apr 2015, accepted on 04 Jun 2015 and first published on 04 Jun 2015


Article type: Paper
DOI: 10.1039/C5PP00144G
Author version
available:
Download author version (PDF)
Citation: Photochem. Photobiol. Sci., 2015,14, 1357-1366
  •   Request permissions

    Photochemical internalization of bleomycin and temozolomide – in vitro studies on the glioma cell line F98

    O. A. Gederaas, A. Hauge, P. G. Ellingsen, K. Berg, D. Altin, T. Bardal, A. Høgset and M. Lindgren, Photochem. Photobiol. Sci., 2015, 14, 1357
    DOI: 10.1039/C5PP00144G

Search articles by author

Spotlight

Advertisements